A rare complication after allogeneic stem cell transplantation: post-transplant erythrocytosis

Clin Transplant. 2016 Jun;30(6):669-72. doi: 10.1111/ctr.12741. Epub 2016 May 2.

Abstract

Post-transplant erythrocytosis is an infrequent complication and has been reported after allogeneic hematopoietic stem cell transplantation (allo-HSCT) in aplastic anemia, acute myeloid leukemia, and chronic myeloid leukemia. The pre-disposing factors and treatment are not clearly defined. We present 11 post-transplant erythrocytosis cases. More studies should be conducted to distinguish the pathogenesis and follow-up for this rare complication.

Keywords: allogeneic stem cell transplantation; complication; erythrocytosis; hemoglobin; post-transplant.

MeSH terms

  • Adolescent
  • Adult
  • Female
  • Hematopoietic Stem Cell Transplantation / adverse effects*
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / complications*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy
  • Leukemia, Myeloid, Acute / complications*
  • Leukemia, Myeloid, Acute / therapy
  • Male
  • Middle Aged
  • Polycythemia / diagnosis
  • Polycythemia / etiology*
  • Retrospective Studies
  • Transplantation, Homologous
  • Young Adult